Literature DB >> 12891929

Early multi-system organ failure associated with acute pancreatitis: a plea for a conservative therapeutic strategy.

T Dugernier1, M Reynaert, P F Laterre.   

Abstract

The mortality of severe acute pancreatitis still ranges between 10 and 20%. Nowadays, infected pancreatic necrosis is the leading cause of death. Despite advances in intensive care therapy, however, early and worsening multi-system organ failure remains a source of substantial morbidity and still accounts for 20 to 50% of the deaths. In recent years, the systemic inflammatory response syndrome and the relevant cascades of inflammatory mediators have been implicated as the key factor in the emergence of remote tissue damage. Early multi-system organ failure that supervenes in the first week is typically associated with a sterile necrotizing process. There are no pathophysiological, clinical or economical data to support the practice of debridement of sterile necrosis to prevent or to control early multi-system organ failure. This issue has never been addressed in a controlled study. Besides intensive care support, non-surgical therapeutic modalities including urgent endoscopic sphincterotomy for impacted stones, antibiotic prophylaxis for the prevention of pancreatic infection and early jejunal nutrition have been specifically developed hopefully to attenuate multiple organ failure, to obviate the need of surgical drainage and to improve survival. Fine needle aspiration of necrotic areas must be incorporated in any conservative therapeutic strategy in order to identify and not to jeopardize those with infected necrosis that remains an absolute indication for drainage. A specific treatment of acute pancreatitis is still lacking, so far. However, there is ample experimental and pathophysiological evidence in favour of immunomodulatory therapy in severe acute pancreatitis. The administration of one or several antagonists of inflammatory mediators possibly combined with a protease inhibitor may at last provide the opportunity to interfere with the two major determinants of prognosis: the severity of multiple organ failure and the extent of necrotic areas that creates the culture medium for bacterial superinfection. These benefits remain to be substantiated in a controlled study, however.

Entities:  

Mesh:

Year:  2003        PMID: 12891929

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  6 in total

1.  Relative adrenal insufficiency in patients with severe acute pancreatitis.

Authors:  Jan J De Waele; Eric A J Hoste; Didier Baert; Koen Hendrickx; Dirk Rijckaert; Patrick Thibo; Philippe Van Biervliet; Stijn I Blot; Francis Colardyn
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

2.  Early recognition of abdominal compartment syndrome in patients with acute pancreatitis.

Authors:  Zilvinas Dambrauskas; Audrius Parseliunas; Antanas Gulbinas; Juozas Pundzius; Giedrius Barauskas
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

3.  Prediction of early death in severe acute pancreatitis.

Authors:  Makoto Shinzeki; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Naoki Matsumura; Hidehiro Sawa; Takahiro Nakajima; Ippei Matsumoto; Tsunenori Fujita; Tetsuo Ajiki; Yasuhiro Fujino; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

4.  Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China.

Authors:  Hou-Quan Tao; Jing-Xia Zhang; Shou-Chun Zou
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

5.  Intra-abdominal hypertension in patients with severe acute pancreatitis.

Authors:  Jan J De Waele; Eric Hoste; Stijn I Blot; Johan Decruyenaere; Francis Colardyn
Journal:  Crit Care       Date:  2005-07-06       Impact factor: 9.097

6.  Is minimally invasive surgical treatment justified for severe acute necrotizing pancreatitis patients with dysfunction of two or more organ systems?

Authors:  Audrius Šileikis; Emilija Pečiulytė; Agnė Misenkienė; Andrius Klimašauskas; Virgilijus Beiša; Kęstutis Strupas
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-07-03       Impact factor: 1.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.